SAMLYN CAPITAL, LLC

Position in NEO — Neogenomics Inc

CIK 1421097 New York, NY

Position in NEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$18,975,527

+$2,650,050 QoQ

Shares Held

2,557,349

+84.2% QoQ

Ownership

1.96%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SAMLYN CAPITAL, LLC holds $82,170,944 across 3 Diagnostics & Research names. NEO ranks #3 (23.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ILMN	Illumina, Inc.	325,999	$40,182,635
2	GH	Guardant Health, Inc.	249,137	$23,012,782
3	NEO	Neogenomics Inc This page	2,557,349	$18,975,527

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,975,527	2,557,349	+84.2%	Shares	Defined	2026-05-15
2025-12-31	$16,325,477	1,388,221	—	Shares	Defined	2026-02-17
No filing history on record for this holder in this stock.